药 物 回 收
|
| |
| Canada: Recall: APO-AMITRIPTYLINE 10mg Tablet (English only) |
| |
Health Canada announces that Apotex Inc. is recalling one lot of APO-AMITRIPTYLINE 10mg Tablet (lot number: RF0410) from retailers, wholesalers and healthcare establishments due to presence of higher than accepted levels of a nitrosamine impurity known as N-nitrosodimethylamine (NDMA) in the affected lot.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../75397r-eng.php
In Hong Kong, Apo-Amitriptyline Tab 10mg (HK-09273) is a pharmaceutical product registered by Hind Wing Co Ltd (Hind Wing), and is a prescription-only medicine.
On 15 Apr 2021, the Department of Health endorsed Hind Wing to recall one lot of Apo-Amitriptyline Tab 10mg (HK-09273) (lot number: RF0410) from the market due to presence of impurity. A press statement was issued on the same date. The DH will continue to monitor the recall.
Ends/Thursday, Apr 15, 2021
Issued at HKT 18:00
|
| |
|
